You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

desensitization strategies in heart transplant patients

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)

Enrolling by invitation
  • Antibody-mediated Rejection
  • Cardiac Transplant
  • Daratumumab and hyaluronidase-fihj
  • Rochester, Minnesota
    Mayo Clinic Rochester
Apr 11, 2022

Hemodynamic Testing Strategies to Assess Pulmonary Hypertension

Recruiting
  • Heart Failure
  • Right Heart Catheterization
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Jan 4, 2023

Sensitisation, Highly Sensitised Dialysis Patients Trial in La Tronche (Each patient will undergo in the first step of the study

Recruiting
  • Sensitisation
  • Highly Sensitised Dialysis Patients
  • Each patient will undergo in the first step of the study belatacept treatment and in the second apheresis and daratumumab
  • La Tronche, France
    Chu Grenoble
May 12, 2022

MISP 60528 Pneumococcal Vaccination

Active, not recruiting
  • Heart Transplant Infection Prevention
  • PCV15
  • Bronx, New York
    Montefiore Medical Center, Infectious Diseases
Dec 15, 2022

Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant, Left Ventricular Dysfunction Trial in Los Angeles

Completed
Has Results
  • Antibody-mediated Rejection
  • +4 more
  • Los Angeles, California
    Cedars Sinai Medical Center, Heart Institute
Apr 30, 2021

Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

Not yet recruiting
  • Kidney Transplant
  • +2 more
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Eye Movement Desensitization and Reprocessing Intervention, Blood Pressure, Heart Rate Variability Trial in Taipei (Eye Movement

Completed
  • Eye Movement Desensitization and Reprocessing Intervention
  • +3 more
  • Eye Movement Desensitization and Reprocessing
  • Taipei, Neihu, Taiwan
    Chen, miao-yi
Apr 18, 2023

Immune Response in Desensitized Patients

Not yet recruiting
  • Kidney Transplant Rejection
  • Desensitization
  • (no location specified)
Mar 26, 2023

Kidney Transplantation in Highly Sensitized Patients Trial in United States (drug, procedure, other)

Recruiting
  • Kidney Transplantation in Highly Sensitized Patients
  • Birmingham, Alabama
  • +12 more
Jan 12, 2023

SUSTAIN-IT: Sustaining Quality of Life of Aged: Heart Transplant

Completed
  • Heart Failure
    • Birmingham, Alabama
    • +12 more
    Feb 14, 2022

    Covid-19 Vaccine Response in Heart Transplant Recipients

    Not yet recruiting
    • Heart Transplantation
    • +2 more
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    Mar 7, 2022

    Immune System Disorder Trial in Spain, United States (Isatuximab SAR650984, Acetaminophen (paracetamol) or equivalent,

    Completed
    • Immune System Disorder
    • Isatuximab SAR650984
    • +5 more
    • San Francisco, California
    • +5 more
    May 6, 2022

    Blood Test for Acute Cardiac Transplant Rejection

    Recruiting
    • Heart Transplant Failure and Rejection
    • +5 more
      • Omaha, Nebraska
      • +3 more
      May 16, 2022

      Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

      Not yet recruiting
      • Antibody-mediated Rejection
      • Allosensitization
      • New York, New York
        NYU Langone Health
      May 16, 2023

      Implementation Science, Heart Transplant, Decision Making Trial in Indianapolis (SOCIAL HF)

      Enrolling by invitation
      • Implementation Science
      • +5 more
      • SOCIAL HF
      • Indianapolis, Indiana
        Indiana University
      Sep 6, 2022

      Cytomegalovirus Infections, Transplant-Related Disorder Trial in Philadelphia (Letermovir 480 MG [Prevymis])

      Not yet recruiting
      • Cytomegalovirus Infections
      • Transplant-Related Disorder
      • Letermovir 480 MG [Prevymis]
      • Philadelphia, Pennsylvania
        Penn Medicine at the University of Pennsylvania
      Sep 27, 2023

      Kidney Transplantation, End Stage Kidney Disease (ESRD) Trial in Chicago (Belatacept Injection)

      Recruiting
      • Kidney Transplantation
      • End Stage Kidney Disease (ESRD)
      • Belatacept Injection
      • Chicago, Illinois
        University of Chicago
      May 13, 2022

      Decreased Immunologic Activity, Antibody-mediated Rejection Trial in Vienna (Combined apheresis)

      Terminated
      • Decreased Immunologic Activity
      • Antibody-mediated Rejection
      • Combined apheresis
      • Vienna, Austria
        Division of Medicine III, Dpt. of Nephrology and Dialysis, Medic
      Aug 22, 2022

      Cardiac Resynchronization Therapy, Heart Failure Trial (Conduction system pacing, Biventricular pacing)

      Not yet recruiting
      • Cardiac Resynchronization Therapy
      • Heart Failure
      • Conduction system pacing
      • Biventricular pacing
      • (no location specified)
      Oct 26, 2023

      Highly Sensitized Prospective Kidney Transplant Recipients Trial in Durham (carfilzomib, belatacept, Bone marrow aspiration)

      Recruiting
      • Highly Sensitized Prospective Kidney Transplant Recipients
      • carfilzomib
      • +2 more
      • Durham, North Carolina
        Duke Transplant Center, Duke University Medical Center
      Jan 11, 2022

      Highly Sensitized Prospective Kidney Transplant Recipients Trial in San Francisco (daratumumab, belatacept, Bone marrow

      Recruiting
      • Highly Sensitized Prospective Kidney Transplant Recipients
      • daratumumab
      • +2 more
      • San Francisco, California
        University of California at San Francisco Medical Center
      Jan 27, 2022

      Kidney Transplant Rejection, Positive FCXM (T or B Cell Positive), Positive CDC Cross-Match (B Cell Positive) Trial in Chicago

      Recruiting
      • Kidney Transplant Rejection
      • +3 more
      • Spleen Transplantation/Removal
      • Chicago, Illinois
        University of Illinois at Chicago
      Mar 30, 2021

      Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

      Active, not recruiting
      • Kidney Failure, Chronic
      • +6 more
      • Los Angeles, California
        Norko Ammerman
      Mar 25, 2022

      Study of Heart Transplant Rejection

      Completed
      • Heart Transplantation
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 7, 2023

        Mitochondrial Substrate Utilization in the Diabetic Human Heart

        Recruiting
        • Heart Failure
        • +4 more
          • Düsseldorf, Germany
            University-Hospital Düsseldorf Division of Cardiology, Pulmonary
          Jul 14, 2023